1-3 of 3
Carmella vandeVen, MA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetically Engineered Natural Killer (NK) Cell Immunotherapy for Poor Risk B-Cell (CD20 + ) Leukemia and Lymphoma

Yaya Chu, PhD, Janet Ayello, MS, MT(ASCP), Jessica Hochberg, MD, Carmella vandeVen, MA, James Murphy, Andrew Stier, Mitchell S. Cairo, MD
Journal: Blood
Blood (2011) 118 (21): 1003.
https://doi.org/10.1182/blood.V118.21.1003.1003
Published: 2011
Journal Articles

Genetically Reengineered K562 Cells Significantly Expand Cord Blood (CB) Natural Killer (NK) Cells Ex-Vivo Expanded with Increased NK Cell Activation and Cytolytic Activity Both In-Vitro and In-Vivo: Potential Use In Adoptive Cellular Immunotherapy (ACI)

Michele Levin, MD, Janet Ayello, MS, MT(ASCP), Frances Zhao, MS, Andrew Stier, Lauren Tiffen, William Quish, Carmella vandeVen, MA, Laxmi V. Baxi, MD, Jessica Hochberg, MD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2010) 116 (21): 3928.
https://doi.org/10.1182/blood.V116.21.3928.3928
Published: 2010
Journal Articles

Mosaic Pattern of Cpg Island methylation in Unrestricted Somatic Cells (USSC) Derived From Human Umbilical Cord Blood (HUCB).

Albert Yang, Yanling Liao, PhD, Jeremy Gold, Lena Street, Laxmi V Baxi, MD, Janet Ayello, MS, MT(ASCP), Carmella vandeVen, MA, Mitchell S. Cairo, MD
Journal: Blood
Blood (2010) 116 (21): 2608.
https://doi.org/10.1182/blood.V116.21.2608.2608
Published: 2010